Author

C. H. P. Cheung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:E. coli· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Assay:clinical cohort / trial· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

K. J. Heesom· 3 shared M. B. Avison· 2 shared P. Dulyayangkul· 2 shared A. P. MacGowan· 1 shared F. Hamilton· 1 shared M. Albur· 1 shared M. Alorabi· 1 shared M. Avison· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

K. J. Heesom

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 13, 2021

Resistance to aztreonam in combination with non-β-lactam β-lactamase inhibitors due to the layering of mechanisms in Escherichia coli identified following mixed culture selection.

C. H. P. Cheung, P. Dulyayangkul, K. J. Heesom, M. Avison

The paper identifies layered resistance mechanisms in Escherichia coli to aztreonam combined with β-lactamase inhibitors through mixed culture selection.

DOI 10.1101/615336

E. coliexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivOct 24, 2020

Trade-Offs Between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamase by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting.

C. H. P. Cheung, M. Alorabi, F. Hamilton…·M. B. Avison

The paper shows how meropenem resistance via NDM-1 in Enterobacteriales involves trade-offs between resistance and fitness, leading to sporadic resistance emergence in clinical settings.

DOI 10.1128/aac.02412-20

humanclinical cohort / trial

𝕏 PostBluesky

MicrobiologybioRxivMay 5, 2020

Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae.

C. H. P. Cheung, P. Dulyayangkul, K. J. Heesom, M. B. Avison

This study uses proteomics to investigate how mutations in MgrB, PhoPQ, and PmrAB affect Arn protein production and colistin resistance in Klebsiella pneumoniae.

DOI 10.1128/aac.00790-20

E. coliproteomics

𝕏 PostBluesky